Darunavir Ethanolate

CAS 635728-49-3 10 current records 2 historicalSmall Molecule

Who holds supplier records for Darunavir Ethanolate? 10 organisations hold a current record for Darunavir Ethanolate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Darunavir Ethanolate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/darunavir-ethanolate

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Darunavir Ethanolate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China1Country not recorded for 1
Need Darunavir Ethanolate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Darunavir Ethanolate are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Darunavir Ethanolate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201127).

Chemical identity

IUPAC name
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;ethanol
Canonical SMILES
CCO.CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
InChIKey
QWSHKNICRJHQCY-VBTXLZOXSA-N
Synonyms
Darunavir (as ethanolate), Darunavir ethanolate, Darunavir ethanolate component of prezcobix, Darunavir ethanolate component of symtuza darunavir, Darunavir monoethanolate, Prezista, Rezolsta, Tmc114 ethanolate, PREZCOBIX COMPONENT DARUNAVIR ETHANOLATE, RefChem:56285, Darunavir (Ethanolate), Darunavir Ethanolate (Prezista)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Protease Inhibitor
Mechanism of action
Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inhibitors; HIV Protease Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Darunavir Ethanolate?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Darunavir Ethanolate: Hetero Labs Limited (India), Arene Life Sciences Limited (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Cipla Limited (India), Laurus Labs Limited (India), LUPIN MANUFACTURING SOLUTIONS LTD, MATRIX PHARMACORP PRIVATE LTD (India) and MICRO LABS LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Darunavir Ethanolate Drug Master Files are active?

Hetero Labs Limited (DMF 27997, 31011), Arene Life Sciences Limited (DMF 37916), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 36976), Cipla Limited (DMF 23662), Laurus Labs Limited (DMF 38980), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 31498), MATRIX PHARMACORP PRIVATE LTD (DMF 30735) and MICRO LABS LTD (DMF 29157) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Darunavir Ethanolate records mean?

2 organisations have only inactive Type II DMFs for Darunavir Ethanolate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Darunavir Ethanolate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Darunavir Ethanolate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.